IL6 and diabetes mellitus: JNK is a subfamily of MAPKs and plays a critical role in the regulation of insulin signaling, inflammation, apoptosis, and caspase-3 activity in diabetes and the upregulation of pro-inflammatory cytokines such as MCP-1, IL-6, IL-8, and TNF-α in AD pathology [52].